J Neurosci 24 : 81418152
CagriSema vs Tirzepatide (REDEFINE 4): strong weight loss, but an important endpoint miss Novo Nordisk has announced headline results from the open-label phase 3 REDEFINE 4 trial comparing CagriSema (cagrilintide + semaglutide) vs tirzepatide 15 mg in obesity
Clinical Strategies to Minimize Weight Rebound and Support Long-Term Stability Evidence-based approaches to prevent rebound include: maintaining or increasing physical activity during treatment (establishing habit before medication stops), adopting a protein-rich, low-glycemic diet, and considering extended or maintenance-dose therapy rather than abrupt discontinuation
Mitochondrion 12(1):3540 Folbergrov J, Jeina P, Othal J (2021) Treatment with resveratrol ameliorates mitochondrial dysfunction during the acute phase of status epilepticus in immature rats
Well, youll receive the same level of medically guided, personalised care
The S 2p spectrum indicated the presence of organosulfur species in PPS, and the peaks were located at 163.6 and 164.8 eV (shown in Fig